mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.1 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |